Financial Conflict of Interest and Academic Influence Among Experts Speaking on Behalf of the Pharmaceutical Industry at the US Food and Drug Administration’s Oncologic Drugs Advisory Committee Meetings

http://www.mayoclinicproceedings.org/article/S0025-6196(17)30319-1/abstract

See:

The Corruption of Academic Medicine